Ceftezole
Ceftezole[edit]
Ceftezole is a beta-lactam antibiotic belonging to the cephalosporin class. It is used primarily in the treatment of bacterial infections caused by susceptible organisms. As a first-generation cephalosporin, ceftezole is effective against a range of Gram-positive bacteria and some Gram-negative bacteria.
Mechanism of Action[edit]
Ceftezole works by inhibiting bacterial cell wall synthesis. It binds to penicillin-binding proteins (PBPs) located inside the bacterial cell wall, which are essential for the cross-linking of the peptidoglycan layer. This inhibition leads to the weakening of the cell wall and ultimately causes bacterial cell lysis and death.
Pharmacokinetics[edit]
Ceftezole is administered via intravenous or intramuscular injection. It is well absorbed and distributed throughout the body, reaching therapeutic concentrations in various tissues and fluids. The drug is primarily excreted unchanged in the urine, making it effective for treating urinary tract infections.
Clinical Uses[edit]
Ceftezole is indicated for the treatment of infections caused by susceptible strains of bacteria, including:
- Skin and soft tissue infections
- Respiratory tract infections
- Urinary tract infections
- Bone and joint infections
Side Effects[edit]
Common side effects of ceftezole include gastrointestinal disturbances such as nausea, vomiting, and diarrhea. Some patients may experience allergic reactions, including rash, pruritus, and, in rare cases, anaphylaxis.
Resistance[edit]
Bacterial resistance to ceftezole can occur through the production of beta-lactamase enzymes, which hydrolyze the beta-lactam ring, rendering the antibiotic ineffective. Resistance can also arise from alterations in PBPs or decreased permeability of the bacterial cell wall.
